Skip to main content
Clinical Trials/NCT00560443
NCT00560443
Completed
Phase 4

Randomized Controlled Trial on Effectiveness of Ketorolac and Tramadol in Not Compound Fractures of Child

IRCCS Burlo Garofolo1 site in 1 country133 target enrollmentFebruary 2008

Overview

Phase
Phase 4
Intervention
ketorolac
Conditions
Fracture
Sponsor
IRCCS Burlo Garofolo
Enrollment
133
Locations
1
Primary Endpoint
estimation of pain reduction in every arm of the trial with linear 1-10 pain scale or for children 4 - 6 years old with analogic MacGrath type scale
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Randomized double blind Trial with the aim to estimate effectiveness of two therapeutic regimes per os on pain due to not compound bone fractures in child 4-17 years old:

  • ketorolac 0,5 mg/kg (1 drop every 2 Kg)
  • tramadol 2,5 mg/Kh (1 drop every 2 Kg)

Intensity of pain will be estimated with linear 1 to 10 or analogic McGrath type scale every 20 min.

The main objectives are the evaluation of pain decreasing in every group, the time of decreasing, the intensity of pain during procedures (ex. Xray) and the occurrence of side effects Secondary outcomes are comparison between the two groups on effectiveness on pain and on side effects

Registry
clinicaltrials.gov
Start Date
February 2008
End Date
April 2012
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
IRCCS Burlo Garofolo
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children 4-17 years old with not compound bone fracture presenting in emergency room

Exclusion Criteria

  • Compound fracture
  • Occurring pain still treated
  • Contraindicated ketorolac or tramadol use
  • Informed consensus not obtained

Arms & Interventions

1

children 4-17 y. old with not compound bone fracture treated with ketorolac

Intervention: ketorolac

2

children 4-17 y. old with not compound bone fracture treated with tramadol

Intervention: tramadol

Outcomes

Primary Outcomes

estimation of pain reduction in every arm of the trial with linear 1-10 pain scale or for children 4 - 6 years old with analogic MacGrath type scale

Time Frame: 6 hours (or until the end of procedures)

Secondary Outcomes

  • comparison between the two groups on effectiveness on pain, measured with linear and analogic scale (see above)(6 hours or until the end of procedures)

Study Sites (1)

Loading locations...

Similar Trials